Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
42,079,879
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
14,061,920
-
Shares change
-
+1,144,865
-
Total reported value, excl. options
-
$31,922,818
-
Value change
-
+$2,512,314
-
Number of buys
-
16
-
Number of sells
-
8
-
Price
-
$2.27
Institutional Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) as of Q2 2025
As of 30 Jun 2025 InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) had 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,061,920 shares of stock of the company.
Largest 10 holders included Nantahala Capital Management, LLC, Rosalind Advisors, Inc., ORBIMED ADVISORS LLC, Soleus Capital Management, L.P., MARSHALL WACE, LLP, Parkman Healthcare Partners LLC, Velan Capital Investment Management LP, PURA VIDA INVESTMENTS, LLC, Affiance Financial, LLC, and UBS Group AG.
This table shows 36 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.